Trump administration agrees to reconsider frozen and rejected NIH grant applications related to DEI initiatives.1 The U.S. Supreme Court, by a 5-4 vote, allowed the termination of $783 million worth of grants that were linked to DEI research, including studies on heart disease, HIV/AIDS, Alzheimer's disease, addiction, and mental health.[1][2][4] These grants, numbering more than 1,700, were cancelled by three executive orders issued by President Trump after his inauguration in January.1][2][3] Federal Judge William Young ordered the funding restored in June, but the Supreme Court blocked that order, saying that litigation over the grants belongs in the Court of Federal Claims.[1][2][4] At the same time, by a 5-4 vote, the court let stand the invalidation of NIH's internal guidelines on DEI's priorities for future funding.[1][5][4] The legal challenge continues in the appeals court and could lead to a trial on Sept. 15.[2][5][5][5][5] The court's decision to reinstate the grants is expected to be upheld by the Supreme Court.